Papers: 10.3390/cancers12020466

https://doi.org/10.3390/cancers12020466

Venetoclax, a BCL-2 Inhibitor, Enhances the Efficacy of Chemotherapeutic Agents in Wild-Type ABCG2-Overexpression-Mediated MDR Cancer Cells

Cited by: 34
Author(s): Jing-Quan Wang, Jonathan Y. Li, Quincy Teng, Zi‐Ning Lei, Ning Ji, Qingbin Cui, Leli Zeng, Yihang Pan, Dong‐Hua Yang, Zhe‐Sheng Chen
Published: over 6 years ago

Software Mentions 1